Microbot Medical Inc. MBOT
Set alert
As of Nov 2, 10:44 AM ET
- YTD
- -41.75%
- 1 year
- -47.76%
- Open
- 1.10
- Prev close
- 1.09
- Mkt cap
- 78.25M
- Vol
- 290.70K
- Avg vol
- 716.74K
- EPS
- -0.25
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.10
- High
- 1.18
- Forward P/E
- -1.87
- Beta
- 1.63
- Short ratio
- 2.65
- Inst. own
- 7.46%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.9736
- 200-d avg
- 1.00
- 1y target
- 0.00
5D chart
Signals (61)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 3:00 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 2:20 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 12:45 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 12:25 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:15 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:15 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 11:45 AM | 3 days ago |
| MACD: Buy Signal | Oct 30, 10:30 AM | 3 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 3 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 3 days ago |
| MACD: Sell Signal | Oct 30, 9:30 AM | 3 days ago |
| RSI: Overbought | Oct 29, 3:55 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 2:50 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 2:45 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 2:40 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 2:30 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 2:00 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 12:10 PM | 3 days ago |
| SMA: Bullish | Oct 29, 11:00 AM | 4 days ago |
| MACD: Buy Signal | Oct 29, 10:10 AM | 4 days ago |
| SMA: Bullish | Oct 29, 10:05 AM | 4 days ago |
| MACD: Sell Signal | Oct 29, 9:35 AM | 4 days ago |
| SMA: Bearish | Oct 29, 9:30 AM | 4 days ago |
| SMA: Bearish | Oct 29, 9:30 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:30 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 3:20 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:05 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:00 PM | 4 days ago |
| SMA: Bearish | Oct 28, 1:15 PM | 4 days ago |
| SMA: Bearish | Oct 28, 1:15 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:50 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:50 PM | 4 days ago |
| SMA: Bearish | Oct 28, 11:20 AM | 5 days ago |
| MACD: Sell Signal | Oct 28, 11:00 AM | 5 days ago |
| RSI: Overbought | Oct 28, 10:25 AM | 5 days ago |
| RSI: Overbought | Oct 28, 10:00 AM | 5 days ago |
| RSI: Overbought | Oct 28, 9:50 AM | 5 days ago |
| RSI: Overbought | Oct 28, 9:35 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 3:30 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 3:20 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 2:50 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:10 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 11:40 AM | 6 days ago |
| RSI: Overbought | Oct 27, 11:35 AM | 6 days ago |
| RSI: Overbought | Oct 27, 10:50 AM | 6 days ago |
| SMA: Bullish | Oct 27, 10:35 AM | 6 days ago |
| SMA: Bearish | Oct 27, 10:10 AM | 6 days ago |
| SMA: Bullish | Oct 27, 9:30 AM | 6 days ago |
| RSI: Overbought | Oct 27, 9:30 AM | 6 days ago |
| SMA: Bullish | Oct 26, 3:50 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 3:30 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 2:25 PM | 6 days ago |
| RSI: Oversold | Oct 26, 2:25 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 2:15 PM | 6 days ago |
| SMA: Bearish | Oct 26, 1:30 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 1:30 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 1:25 PM | 6 days ago |
| SMA: Bullish | Oct 26, 1:20 PM | 6 days ago |
| SMA: Bearish | Oct 26, 11:55 AM | 6 days ago |
| SMA: Bearish | Oct 26, 10:30 AM | 1 week ago |
| SMA: Bullish | Oct 26, 10:20 AM | 1 week ago |
News
-
6 days ago benzinga.com
Microbot Medical Receives Order From ELMNT IR For 12-Month Supply Of Liberty Devices
Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY Endovascular Robotic System, today announced that ELMNT IR, a multisite outpatient interventional radiology…
6 days ago globenewswire.com
Microbot Medical® Secures its First Office-Based Lab (OBL) Customer for the LIBERTY® Endovascular Robotic System
ELMNT IR also became the first account on the West Coast, marking a geographic expansion which aligns with the Company's Full Market Release strategy. The Company believes the OBLs represent a…
-
1 week ago benzinga.com
Citizens Initiates Coverage On Microbot Medical with Market Outperform Rating, Announces Price Target of $2.5
Citizens analyst Daniel Stauder initiates coverage on Microbot Medical (NASDAQ:MBOT) with a Market Outperform rating and announces Price Target of $2.5.
1 week ago globenewswire.com
Microbot Medical® Attending Key Medical Conference to Engage with Decision-makers as it Continues to Expand Presence Across the U.S.
HINGHAM, Mass., Oct. 23, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, today announced that key…
-
1 week ago benzinga.com
HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and maintains $12 price target.
-
1 week ago benzinga.com
Microbot Medical Receives Several New Patent Approvals Across US, Japan, China And Canada, Further Strengthening Its Global IP Portfolio
The Company now holds 44 issued patents and 49 pending patents globally. Commercialization continues to advance across both U.S. and international markets.HINGHAM, Mass., Oct. 20, 2026 (GLOBE…
1 week ago globenewswire.com
Microbot Medical® Granted Multiple New Patents, Further Strengthening Its Global Intellectual Property Portfolio
The Company now holds 44 issued patents and 49 pending patents globally. Commercialization continues to advance across both U.S. and international markets.
-
3 weeks ago benzinga.com
Microbot Medical Inks Three-Year Distribution Deal With Medtechnica To Advertise, Sell LIBERTY System In Israel
Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced that it has signed a three-year exclusive commercial distribution…
3 weeks ago globenewswire.com
Microbot Medical® and Medtechnica Ltd. Enter into Three-Year Exclusive Distribution Agreement in Israel
Medtechnica Ltd., a Leading Medical Device Distributor in Israel, Authorized to Distribute the LIBERTY® Endovascular Robotic System Throughout Israel Microbot Medical is Executing its International…
1 month ago globenewswire.com
Microbot Medical® Highlights Growth Strategy
Service Unavailable Service Unavailable HTTP Error 503. The service is unavailable.
2 months ago defenseworld.net
Financial Analysis: Koninklijke Philips (NYSE:PHG) & Microbot Medical (NASDAQ:MBOT)
Koninklijke Philips (NYSE: PHG - Get Free Report) and Microbot Medical (NASDAQ: MBOT - Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two…
-
2 months ago benzinga.com
B. Riley Securities Reiterates Buy on Microbot Medical, Lowers Price Target to $4
B. Riley Securities analyst Anderson Schock reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and lowers the price target from $5 to $4.
2 months ago zacks.com
Microbot Medical Inc. (MBOT) Reports Q2 Loss, Lags Revenue Estimates
Microbot Medical Inc. (MBOT) came out with a quarterly loss of $0.08 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.1 per share a year ago.
-
2 months ago benzinga.com
Microbot Medical Q2 EPS $(0.08), Inline, Sales $241.000K Miss $340.000K Estimate
Microbot Medical (NASDAQ:MBOT) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is a 20 percent increase over losses of $(0.10) per share from the same…
2 months ago globenewswire.com
Microbot Medical® Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second Quarter
Revenue increased by more than 100% over the prior fiscal quarter, driven by repeat orders, expanded utilization among existing customers, and the acquisition of new customers since the Full Market…
3 months ago zacks.com
New Strong Buy Stocks for July 23rd
PLGO, BLPD, INN, RFIL and MBOT have been added to the Zacks Rank #1 (Strong Buy) List on July 23, 2026.
3 months ago globenewswire.com
Microbot Medical® Among Featured Companies Showcasing Novel Robotic Technologies and Digital Surgery Applications at the Society of Robotic Surgery Annual Meeting
HINGHAM, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, will be participating at this…
-
3 months ago benzinga.com
Microbot Medical Reports 100% Growth In Revenue, New Clients In Q2
Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, is reporting greater than 100% growth in revenue and new customers for the…
3 months ago globenewswire.com
Microbot Medical® Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in the Second Quarter of 2026
The Company is experiencing rising demand and increasing pipeline for the LIBERTY System since commencing the Full Market Release in April Heightened awareness generating interest from leading health…
-
4 months ago benzinga.com
Microbot Medical Signs Letter With Manufacturer Sanmina To Produce Its LIBERTY Single-Use, Remotely Operated Endovascular Robotic System
As momentum continues to rise in the U.S., reflected in increased accounts and usage across several states, and with the momentum building in the international markets as seen with the recent…
4 months ago globenewswire.com
Microbot Medical® Increases Manufacturing Capacity as Demand for the LIBERTY® System Rises; Enters into Strategic Agreement with Sanmina, a Global Manufacturing Leader
HINGHAM, Mass., June 30, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, has entered into a Letter of…
4 months ago globenewswire.com
Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System
HINGHAM, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced that it has won the…
4 months ago globenewswire.com
Microbot Medical® Announces First Health System in Pennsylvania to Adopt the LIBERTY® Endovascular Robotic System
Leading academic center with multi-hospital and multi-state health system deepens Company's footprint in the Northeast U.S. The Company now has multiple accounts and hospitals that have adopted the…
-
4 months ago benzinga.com
Microbot Medical Inks Agreement With Lovell Government Services To Serve Federal Healthcare Systems
Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, has entered into an agreement with Lovell® Government Services to serve federal…
4 months ago globenewswire.com
Microbot Medical® Enters Into an Agreement to Expand Access for America's Veteran and Military Patient Populations
HINGHAM, Mass., June 16, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, has entered into an agreement…
4 months ago globenewswire.com
Microbot Medical® Announces a Notable Health System as the First in Michigan to Adopt the LIBERTY® Endovascular Robotic System
HINGHAM, Mass., June 09, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced that one of the…
-
5 months ago benzinga.com
LUCID CAPITAL MARKETS Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $4
LUCID CAPITAL MARKETS analyst Alex Nowark initiates coverage on Microbot Medical (NASDAQ:MBOT) with a Buy rating and announces Price Target of $4.
5 months ago globenewswire.com
Microbot Medical® Secures the First Healthcare System in North Carolina to Adopt the LIBERTY® Endovascular Robotic System
HINGHAM, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced that it has secured…
-
5 months ago benzinga.com
Microbot Medical Receives Israel's Marketing Clearance For Its LIBERTY System
Microbot Medical Inc. (NASDAQ:MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced that it has achieved a significant regulatory milestone as Israel…
5 months ago globenewswire.com
Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System
Israel becomes the second jurisdiction and the first outside of the U.S. to grant marketing clearance for the LIBERTY System The AMAR regulatory approval will enable the Company to obtain a Free Sale…
5 months ago zacks.com
After Plunging 22.6% in 4 Weeks, Here's Why the Trend Might Reverse for Microbot Medical (MBOT)
Microbot Medical (MBOT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings…
5 months ago seekingalpha.com
Microbot Medical Inc. (MBOT) Shareholder/Analyst Call Transcript
Microbot Medical Inc. (MBOT) Shareholder/Analyst Call Transcript
-
5 months ago benzinga.com
Watching Microbot Medical; Shares See Volume To The Downside; White Diamond Research Issues Report On Co
https://whitediamondresearch.com/research/we-interviewed-some-of-the-first-surgeons-to-use-microbot-medicals-liberty-endovascular-robotic-system-and-its-clear-that-it-will-be-a-commercial-failure-1-pr…
-
6 months ago benzinga.com
Microbot Medical Announces LIBERTY System Gains Clinical Validation And Early Commercial Adoption As Global Expansion Accelerates
Commercial adoption of the LIBERTY System by sites that participated in the clinical trial serves as a strong validation of the value it brings to everyday practiceThe Company will attend the Annual…
-
6 months ago benzinga.com
HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and maintains $12 price target.
-
6 months ago benzinga.com
Microbot Medical Completes Limited Market Release Of Its LIBERTY Endovascular Robotic System, With Commencement Of Full Market Release In The U.S. Proceeding As Planned
To date, LIBERTY has been adopted by multiple healthcare systems with dozens of hospitals in their networks, including globally recognized hospitals such as Emory Healthcare and Tampa General…
-
7 months ago benzinga.com
Microbot Medical Q4 EPS $(0.04) Beats $(0.06) Estimate
Microbot Medical (NASDAQ:MBOT) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.06) by 33.33 percent. This is a 78.95 percent increase over losses of…
-
7 months ago benzinga.com
Emory Healthcare Announces Successful Use Of Microbot Medical's Liberty System In Robotic Peripheral Endovascular Procedures
Emory interventional radiologists have now demonstrated successful use of the LIBERTY System on benign prostatic hyperplasia (BPH, commonly known as enlarged prostate), as well as liver cancer.
-
8 months ago benzinga.com
Microbot Medical Commends American Medical Association's Expanding Efforts To Protect Health Care Professionals From Ionizing Radiation
Microbot Medical Inc. (NASDAQ:MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, commends the American Medical Association's (AMA) expanding efforts to protect…
8 months ago benzinga.com
Tampa General Hospital Adopts Small-Cap Microbot Medical's Robotic System
Microbot Medical stock jumps after Tampa General adopts its FDA-cleared LIBERTY robotic system ahead of April 2026 launch.
-
8 months ago benzinga.com
Microbot Medical Highlights LIBERTY Endovascular Robotic System At ISET Conference
International Symposium on Endovascular Therapy (ISET) Convened Key Opinion Leaders to Discuss Advancements and Future Role of Endovascular RoboticsLIBERTY® Continues to Gain Commercial Traction and…
8 months ago benzinga.com
Looking Into Microbot Medical Inc's Recent Short Interest
Looking Into Microbot Medical Inc's Recent Short Interest
8 months ago benzinga.com
This Microbot Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Tuesday
This Microbot Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Tuesday
-
8 months ago benzinga.com
B. Riley Securities Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $5
B. Riley Securities analyst Anderson Schock initiates coverage on Microbot Medical (NASDAQ:MBOT) with a Buy rating and announces Price Target of $5.
8 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
8 months ago benzinga.com
Why Credo Technology Group Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket
Why Credo Technology Group Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket
-
9 months ago benzinga.com
Microbot Medical Says It Enters 2026 With Market Momentum Following FDA 510(k) Clearance Of LIBERTY, Single‑Use Endovascular Robotic System
Limited Market Release (LMR) of the LIBERTY® System is on ScheduleBuilding on Positive Customer Feedback and Growing Market Enthusiasm, the Company Prepares for Full Market Release (FMR) in…
-
11 months ago benzinga.com
Roth Capital Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $5.5
Roth Capital analyst Kyle Bauser initiates coverage on Microbot Medical (NASDAQ:MBOT) with a Buy rating and announces Price Target of $5.5.
-
11 months ago benzinga.com
HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and maintains $12 price target.
-
11 months ago benzinga.com
Microbot Medical Says Emory University Hospital Adopts LIBERTY For Patient Care; Microbot Collaborates With Emory To Establish Endovascular Robotics Program In Interventional Radiology
Microbot Medical Inc. (NASDAQ:MBOT), developer and distributor of the innovative LIBERTY Endovascular Robotic System, announced that Emory University Hospital, a nationally recognized academic…